Keyword: Pharmaceuticals

News

Bayer to Invest More Than €500 Million in Haemophilia Pipeline

12.03.2014 - BayerHealthcare plans to invest more than €500 million at its sites in Wuppertal and Leverkusen, Germany, to expand capacity for production of its recombinant factor VIII...

News

WeylChem U.S. Inc. expanding at Kershaw County facility

11.03.2014 - WeylChem U.S. Inc., a provider of custom manufacturing and tolling services, as well as advanced intermediates and reagents is announcing the expansion of its Kershaw County...

News

Lilly-Boehringer Diabetes Drug Halted by FDA

10.03.2014 - In response to an application by U.S. drugmaker Eli Lilly for approval of a New Drug Application (NDA) for its type 2 diabetes treatment empagliflozin, the U.S. Food and Drug...

Plant Construction & Process Technology

Pharma In Africa

05.03.2014 - Up And Up - Long known for its struggles with infectious diseases and poverty, the continent of Africa is experiencing widespread economic growth. An increasing middle class and...

News

Bayer Reaches 92.7% of Takeover Candidate Algeta

27.02.2014 - Bayer group has now met its target for the acquisition of Norwegian pharmaceutical producer Algeta. The German group said on Feb. 26 it had received acceptance from an estimated 97...

News

Cinven Could Acquire Medpace for $900 Million

24.02.2014 - Private equity firm Cinven, based in London, has agreed to acquire U.S. pharmaceutical contract research organization Medpace from buyout firm CCMP Capital Advisors for a little...

News

Reckitt Benckiser Says Pharma Review Ongoing

13.02.2014 - Reckitt Benckiser has said the strategic review of its pharmaceuticals business is still in progress and it will update investors over the course of 2014. In October 2013, the...

News

Researchers Slam EU Opt-out Rules for Pediatric Cancer Drug Trials

12.02.2014 - EU rules dating from 2007, allowing pharmaceutical companies to opt out of pediatric trials with new cancer medicines if the disease they are intended to treat rarely affects...